Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for TCF3_MYOG
Z-value: 1.53
Motif logo
Transcription factors associated with TCF3_MYOG
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TCF3
|
ENSG00000071564.10 | transcription factor 3 |
|
MYOG
|
ENSG00000122180.4 | myogenin |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TCF3 | hg19_v2_chr19_-_1650666_1650744 | 0.84 | 3.0e-06 | Click! |
| MYOG | hg19_v2_chr1_-_203055129_203055164 | -0.30 | 1.9e-01 | Click! |
Activity profile of TCF3_MYOG motif
Sorted Z-values of TCF3_MYOG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_39258461 | 14.21 |
ENST00000440582.1
|
KRTAP4-16P
|
keratin associated protein 4-16, pseudogene |
| chr4_-_41216492 | 7.17 |
ENST00000503503.1
ENST00000509446.1 ENST00000503264.1 ENST00000508707.1 ENST00000508593.1 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr12_-_52887034 | 6.66 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
| chr8_-_49834299 | 5.86 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
| chr13_-_20767037 | 5.61 |
ENST00000382848.4
|
GJB2
|
gap junction protein, beta 2, 26kDa |
| chr16_+_55522536 | 5.60 |
ENST00000570283.1
|
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
| chr8_-_49833978 | 5.39 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
| chr12_-_52914155 | 5.34 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
| chr19_+_39687596 | 5.26 |
ENST00000339852.4
|
NCCRP1
|
non-specific cytotoxic cell receptor protein 1 homolog (zebrafish) |
| chr3_-_87039662 | 5.20 |
ENST00000494229.1
|
VGLL3
|
vestigial like 3 (Drosophila) |
| chr2_+_219745020 | 5.16 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
| chr1_-_59043166 | 5.11 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr7_+_20370300 | 5.05 |
ENST00000537992.1
|
ITGB8
|
integrin, beta 8 |
| chr19_+_16186903 | 5.03 |
ENST00000588507.1
|
TPM4
|
tropomyosin 4 |
| chr1_+_78354175 | 4.97 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chr6_+_30848740 | 4.78 |
ENST00000505534.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr6_+_30848771 | 4.67 |
ENST00000503180.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr1_-_153538011 | 4.66 |
ENST00000368707.4
|
S100A2
|
S100 calcium binding protein A2 |
| chr6_+_30848829 | 4.59 |
ENST00000508317.1
|
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr17_-_39280419 | 4.53 |
ENST00000394014.1
|
KRTAP4-12
|
keratin associated protein 4-12 |
| chr1_+_2407754 | 4.47 |
ENST00000419816.2
ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2
|
phospholipase C, eta 2 |
| chr4_-_41216619 | 4.32 |
ENST00000508676.1
ENST00000506352.1 ENST00000295974.8 |
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr3_+_41236325 | 4.28 |
ENST00000426215.1
ENST00000405570.1 |
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa |
| chr17_-_7165662 | 4.25 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr8_+_120220561 | 4.22 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
| chr6_+_30848557 | 4.18 |
ENST00000460944.2
ENST00000324771.8 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr1_-_209792111 | 4.18 |
ENST00000455193.1
|
LAMB3
|
laminin, beta 3 |
| chr12_+_56325812 | 4.17 |
ENST00000394147.1
ENST00000551156.1 ENST00000553783.1 ENST00000557080.1 ENST00000432422.3 ENST00000556001.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
| chr11_-_10830463 | 4.11 |
ENST00000527419.1
ENST00000530211.1 ENST00000530702.1 ENST00000524932.1 ENST00000532570.1 |
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr12_-_52867569 | 4.09 |
ENST00000252250.6
|
KRT6C
|
keratin 6C |
| chr13_-_28194541 | 4.07 |
ENST00000316334.3
|
LNX2
|
ligand of numb-protein X 2 |
| chr4_-_41216473 | 4.05 |
ENST00000513140.1
|
APBB2
|
amyloid beta (A4) precursor protein-binding, family B, member 2 |
| chr12_-_120663792 | 4.02 |
ENST00000546532.1
ENST00000548912.1 |
PXN
|
paxillin |
| chr1_+_13910194 | 3.96 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
| chr9_-_117880477 | 3.94 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
| chr18_-_18691739 | 3.79 |
ENST00000399799.2
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1 |
| chr1_+_78354297 | 3.78 |
ENST00000334785.7
|
NEXN
|
nexilin (F actin binding protein) |
| chrX_-_84634708 | 3.77 |
ENST00000373145.3
|
POF1B
|
premature ovarian failure, 1B |
| chr4_-_80994210 | 3.75 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr6_+_18387570 | 3.71 |
ENST00000259939.3
|
RNF144B
|
ring finger protein 144B |
| chr2_-_37899323 | 3.62 |
ENST00000295324.3
ENST00000457889.1 |
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3 |
| chr1_+_78354330 | 3.58 |
ENST00000440324.1
|
NEXN
|
nexilin (F actin binding protein) |
| chr5_+_148960931 | 3.55 |
ENST00000333677.6
|
ARHGEF37
|
Rho guanine nucleotide exchange factor (GEF) 37 |
| chr2_-_1748214 | 3.53 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
| chr6_+_150464155 | 3.52 |
ENST00000361131.4
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr1_+_26872324 | 3.51 |
ENST00000531382.1
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
| chr17_-_7493390 | 3.46 |
ENST00000538513.2
ENST00000570788.1 ENST00000250055.2 |
SOX15
|
SRY (sex determining region Y)-box 15 |
| chr5_-_151066514 | 3.43 |
ENST00000538026.1
ENST00000522348.1 ENST00000521569.1 |
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin) |
| chr10_-_88281494 | 3.41 |
ENST00000298767.5
|
WAPAL
|
wings apart-like homolog (Drosophila) |
| chr3_+_182511266 | 3.37 |
ENST00000323116.5
ENST00000493826.1 |
ATP11B
|
ATPase, class VI, type 11B |
| chr12_-_50616122 | 3.37 |
ENST00000552823.1
ENST00000552909.1 |
LIMA1
|
LIM domain and actin binding 1 |
| chr19_+_45281118 | 3.32 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr17_+_80193644 | 3.23 |
ENST00000582946.1
|
SLC16A3
|
solute carrier family 16 (monocarboxylate transporter), member 3 |
| chr1_-_17304771 | 3.22 |
ENST00000375534.3
|
MFAP2
|
microfibrillar-associated protein 2 |
| chr22_+_41777927 | 3.17 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr4_-_15939963 | 3.15 |
ENST00000259988.2
|
FGFBP1
|
fibroblast growth factor binding protein 1 |
| chr12_-_50616382 | 3.13 |
ENST00000552783.1
|
LIMA1
|
LIM domain and actin binding 1 |
| chr6_+_30852130 | 3.13 |
ENST00000428153.2
ENST00000376568.3 ENST00000452441.1 ENST00000515219.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr5_-_141249154 | 3.11 |
ENST00000357517.5
ENST00000536585.1 |
PCDH1
|
protocadherin 1 |
| chr21_+_30503282 | 2.93 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr1_+_14075865 | 2.93 |
ENST00000413440.1
|
PRDM2
|
PR domain containing 2, with ZNF domain |
| chr5_-_73936451 | 2.89 |
ENST00000537006.1
|
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
| chr3_+_111630451 | 2.89 |
ENST00000495180.1
|
PHLDB2
|
pleckstrin homology-like domain, family B, member 2 |
| chr22_+_17082732 | 2.88 |
ENST00000558085.2
ENST00000592918.1 ENST00000400593.2 ENST00000592107.1 ENST00000426585.1 ENST00000591299.1 |
TPTEP1
|
transmembrane phosphatase with tensin homology pseudogene 1 |
| chr4_-_77819002 | 2.85 |
ENST00000334306.2
|
SOWAHB
|
sosondowah ankyrin repeat domain family member B |
| chr17_+_39382900 | 2.85 |
ENST00000377721.3
ENST00000455970.2 |
KRTAP9-2
|
keratin associated protein 9-2 |
| chr1_+_13910479 | 2.83 |
ENST00000509009.1
|
PDPN
|
podoplanin |
| chr11_-_10829851 | 2.82 |
ENST00000532082.1
|
EIF4G2
|
eukaryotic translation initiation factor 4 gamma, 2 |
| chr3_-_99833333 | 2.80 |
ENST00000354552.3
ENST00000331335.5 ENST00000398326.2 |
FILIP1L
|
filamin A interacting protein 1-like |
| chr21_+_30502806 | 2.76 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
| chr1_+_183155373 | 2.75 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr11_+_86502085 | 2.67 |
ENST00000527521.1
|
PRSS23
|
protease, serine, 23 |
| chr6_+_44095263 | 2.65 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
| chr11_-_62323702 | 2.64 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
| chr1_-_182360918 | 2.63 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
| chr5_+_66124590 | 2.62 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
| chr8_+_38758737 | 2.60 |
ENST00000521746.1
ENST00000420274.1 |
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
| chr18_+_29078131 | 2.57 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr17_-_39316983 | 2.56 |
ENST00000390661.3
|
KRTAP4-4
|
keratin associated protein 4-4 |
| chr19_+_16187085 | 2.53 |
ENST00000300933.4
|
TPM4
|
tropomyosin 4 |
| chr21_+_37692481 | 2.50 |
ENST00000400485.1
|
MORC3
|
MORC family CW-type zinc finger 3 |
| chr8_+_38758845 | 2.47 |
ENST00000519640.1
|
PLEKHA2
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2 |
| chr11_+_128634589 | 2.45 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
| chr17_+_39346139 | 2.42 |
ENST00000398470.1
ENST00000318329.5 |
KRTAP9-1
|
keratin associated protein 9-1 |
| chr11_+_129245796 | 2.41 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
| chr2_-_17981462 | 2.40 |
ENST00000402989.1
ENST00000428868.1 |
SMC6
|
structural maintenance of chromosomes 6 |
| chr12_-_46662888 | 2.35 |
ENST00000546893.1
|
SLC38A1
|
solute carrier family 38, member 1 |
| chr1_-_175161890 | 2.35 |
ENST00000545251.2
ENST00000423313.1 |
KIAA0040
|
KIAA0040 |
| chr1_+_14075903 | 2.33 |
ENST00000343137.4
ENST00000503842.1 ENST00000407521.3 ENST00000505823.1 |
PRDM2
|
PR domain containing 2, with ZNF domain |
| chr11_+_111789580 | 2.33 |
ENST00000278601.5
|
C11orf52
|
chromosome 11 open reading frame 52 |
| chr2_+_14772810 | 2.32 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
| chr5_+_156887027 | 2.30 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
| chr5_-_112630598 | 2.29 |
ENST00000302475.4
|
MCC
|
mutated in colorectal cancers |
| chr3_-_125313934 | 2.29 |
ENST00000296220.5
|
OSBPL11
|
oxysterol binding protein-like 11 |
| chr16_+_57673207 | 2.28 |
ENST00000564783.1
ENST00000564729.1 ENST00000565976.1 ENST00000566508.1 ENST00000544297.1 |
GPR56
|
G protein-coupled receptor 56 |
| chr6_-_42110342 | 2.28 |
ENST00000356542.5
|
C6orf132
|
chromosome 6 open reading frame 132 |
| chr1_-_27339317 | 2.24 |
ENST00000289166.5
|
FAM46B
|
family with sequence similarity 46, member B |
| chr19_+_10736183 | 2.22 |
ENST00000590857.1
ENST00000588688.1 ENST00000586078.1 |
SLC44A2
|
solute carrier family 44 (choline transporter), member 2 |
| chr1_+_78354243 | 2.22 |
ENST00000294624.8
|
NEXN
|
nexilin (F actin binding protein) |
| chr14_+_24867992 | 2.21 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr18_+_21269404 | 2.20 |
ENST00000313654.9
|
LAMA3
|
laminin, alpha 3 |
| chr15_-_40633101 | 2.19 |
ENST00000559313.1
|
C15orf52
|
chromosome 15 open reading frame 52 |
| chr11_+_118401899 | 2.18 |
ENST00000528373.1
ENST00000544878.1 ENST00000354284.4 ENST00000533137.1 ENST00000532762.1 ENST00000526973.1 ENST00000354064.7 ENST00000533102.1 ENST00000313236.5 ENST00000527267.1 ENST00000524725.1 ENST00000533689.1 |
TMEM25
|
transmembrane protein 25 |
| chrX_+_115567767 | 2.17 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
| chr1_+_60280458 | 2.17 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr22_+_31489344 | 2.15 |
ENST00000404574.1
|
SMTN
|
smoothelin |
| chr19_-_53193731 | 2.14 |
ENST00000598536.1
ENST00000594682.2 ENST00000601257.1 |
ZNF83
|
zinc finger protein 83 |
| chr15_-_42749711 | 2.14 |
ENST00000565611.1
ENST00000263805.4 ENST00000565948.1 |
ZNF106
|
zinc finger protein 106 |
| chr14_+_65170820 | 2.11 |
ENST00000555982.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr5_-_73937244 | 2.10 |
ENST00000302351.4
ENST00000510316.1 ENST00000508331.1 |
ENC1
|
ectodermal-neural cortex 1 (with BTB domain) |
| chr11_+_82904858 | 2.09 |
ENST00000260047.6
|
ANKRD42
|
ankyrin repeat domain 42 |
| chr1_-_182361327 | 2.07 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
| chr1_+_25071848 | 2.07 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr3_-_178789220 | 2.07 |
ENST00000414084.1
|
ZMAT3
|
zinc finger, matrin-type 3 |
| chr16_+_23847355 | 2.07 |
ENST00000498058.1
|
PRKCB
|
protein kinase C, beta |
| chr4_+_108815402 | 2.06 |
ENST00000503385.1
|
SGMS2
|
sphingomyelin synthase 2 |
| chr2_-_219146839 | 2.05 |
ENST00000425694.1
|
TMBIM1
|
transmembrane BAX inhibitor motif containing 1 |
| chr6_-_32634425 | 2.03 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
| chr1_-_156675564 | 2.03 |
ENST00000368220.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr12_-_50677255 | 2.02 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
| chr3_+_63897605 | 2.02 |
ENST00000487717.1
|
ATXN7
|
ataxin 7 |
| chr1_-_156675535 | 2.01 |
ENST00000368221.1
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr7_+_116166331 | 1.99 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr12_+_4382917 | 1.99 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
| chr6_+_44095347 | 1.99 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr4_-_80994619 | 1.98 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr18_+_33877654 | 1.96 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chrX_+_131157609 | 1.96 |
ENST00000496850.1
|
MST4
|
Serine/threonine-protein kinase MST4 |
| chr14_+_90863364 | 1.95 |
ENST00000447653.3
ENST00000553542.1 |
CALM1
|
calmodulin 1 (phosphorylase kinase, delta) |
| chr3_-_196910721 | 1.92 |
ENST00000443183.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
| chr19_-_51472823 | 1.91 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chrX_-_73061339 | 1.90 |
ENST00000602863.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
| chr11_-_67188642 | 1.90 |
ENST00000546202.1
ENST00000542876.1 |
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme |
| chr10_+_111765562 | 1.89 |
ENST00000360162.3
|
ADD3
|
adducin 3 (gamma) |
| chr3_+_111718036 | 1.89 |
ENST00000455401.2
|
TAGLN3
|
transgelin 3 |
| chr1_-_85156417 | 1.89 |
ENST00000422026.1
|
SSX2IP
|
synovial sarcoma, X breakpoint 2 interacting protein |
| chr1_-_160990886 | 1.88 |
ENST00000537746.1
|
F11R
|
F11 receptor |
| chr18_+_47088401 | 1.88 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
| chr4_+_47487285 | 1.88 |
ENST00000273859.3
ENST00000504445.1 |
ATP10D
|
ATPase, class V, type 10D |
| chr17_+_36508826 | 1.87 |
ENST00000580660.1
|
SOCS7
|
suppressor of cytokine signaling 7 |
| chr6_-_138833630 | 1.85 |
ENST00000533765.1
|
NHSL1
|
NHS-like 1 |
| chrX_-_107018969 | 1.84 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr11_-_2170786 | 1.84 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr8_+_22435762 | 1.82 |
ENST00000456545.1
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr16_+_23847339 | 1.81 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
| chr3_-_196910477 | 1.80 |
ENST00000447466.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
| chr6_+_30851840 | 1.80 |
ENST00000511510.1
ENST00000376569.3 ENST00000376575.3 ENST00000376570.4 ENST00000446312.1 ENST00000504927.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr20_+_45523227 | 1.80 |
ENST00000327619.5
ENST00000357410.3 |
EYA2
|
eyes absent homolog 2 (Drosophila) |
| chr12_+_14518598 | 1.80 |
ENST00000261168.4
ENST00000538511.1 ENST00000545723.1 ENST00000543189.1 ENST00000536444.1 |
ATF7IP
|
activating transcription factor 7 interacting protein |
| chr3_-_196911002 | 1.79 |
ENST00000452595.1
|
DLG1
|
discs, large homolog 1 (Drosophila) |
| chr4_+_26344754 | 1.78 |
ENST00000515573.1
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
| chr2_+_233562015 | 1.76 |
ENST00000427233.1
ENST00000373566.3 ENST00000373563.4 ENST00000428883.1 ENST00000456491.1 ENST00000409480.1 ENST00000421433.1 ENST00000425040.1 ENST00000430720.1 ENST00000409547.1 ENST00000423659.1 ENST00000409196.3 ENST00000409451.3 ENST00000429187.1 ENST00000440945.1 |
GIGYF2
|
GRB10 interacting GYF protein 2 |
| chr1_-_156675368 | 1.76 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
| chr12_-_95044309 | 1.75 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr7_+_18535346 | 1.75 |
ENST00000405010.3
ENST00000406451.4 ENST00000428307.2 |
HDAC9
|
histone deacetylase 9 |
| chrX_+_47083037 | 1.74 |
ENST00000523034.1
|
CDK16
|
cyclin-dependent kinase 16 |
| chr18_+_72166564 | 1.74 |
ENST00000583216.1
ENST00000581912.1 ENST00000582589.1 |
CNDP2
|
CNDP dipeptidase 2 (metallopeptidase M20 family) |
| chr3_+_111717511 | 1.73 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr11_-_119599794 | 1.71 |
ENST00000264025.3
|
PVRL1
|
poliovirus receptor-related 1 (herpesvirus entry mediator C) |
| chr10_-_98031265 | 1.71 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
| chr12_-_29936731 | 1.71 |
ENST00000552618.1
ENST00000539277.1 ENST00000551659.1 |
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1 |
| chr6_-_10419871 | 1.70 |
ENST00000319516.4
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr19_-_19051103 | 1.66 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr12_+_652294 | 1.66 |
ENST00000322843.3
|
B4GALNT3
|
beta-1,4-N-acetyl-galactosaminyl transferase 3 |
| chr5_+_49962772 | 1.65 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr9_-_13165457 | 1.65 |
ENST00000542239.1
ENST00000538841.1 ENST00000433359.2 |
MPDZ
|
multiple PDZ domain protein |
| chrX_+_9880412 | 1.64 |
ENST00000418909.2
|
SHROOM2
|
shroom family member 2 |
| chrX_+_150151824 | 1.64 |
ENST00000455596.1
ENST00000448905.2 |
HMGB3
|
high mobility group box 3 |
| chr3_+_49507674 | 1.63 |
ENST00000431960.1
ENST00000452317.1 ENST00000435508.2 ENST00000452060.1 ENST00000428779.1 ENST00000419218.1 ENST00000430636.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr2_-_39347524 | 1.61 |
ENST00000395038.2
ENST00000402219.2 |
SOS1
|
son of sevenless homolog 1 (Drosophila) |
| chr1_-_94079648 | 1.60 |
ENST00000370247.3
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
| chr22_-_37823468 | 1.59 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
| chr16_+_57673348 | 1.57 |
ENST00000567915.1
ENST00000564103.1 ENST00000562467.1 |
GPR56
|
G protein-coupled receptor 56 |
| chr11_-_64825993 | 1.56 |
ENST00000340252.4
ENST00000355721.3 ENST00000356632.3 ENST00000355369.2 ENST00000339885.2 ENST00000358658.3 |
NAALADL1
|
N-acetylated alpha-linked acidic dipeptidase-like 1 |
| chr6_-_56716686 | 1.56 |
ENST00000520645.1
|
DST
|
dystonin |
| chr3_-_185538849 | 1.55 |
ENST00000421047.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr19_+_47104553 | 1.55 |
ENST00000598871.1
ENST00000594523.1 |
CALM3
|
calmodulin 3 (phosphorylase kinase, delta) |
| chr11_-_119991589 | 1.55 |
ENST00000526881.1
|
TRIM29
|
tripartite motif containing 29 |
| chr11_-_321050 | 1.54 |
ENST00000399808.4
|
IFITM3
|
interferon induced transmembrane protein 3 |
| chr19_-_11450249 | 1.54 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
| chr11_-_85779786 | 1.52 |
ENST00000356360.5
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein |
| chr2_-_224702201 | 1.52 |
ENST00000446015.2
|
AP1S3
|
adaptor-related protein complex 1, sigma 3 subunit |
| chrX_-_132095419 | 1.52 |
ENST00000370836.2
ENST00000521489.1 |
HS6ST2
|
heparan sulfate 6-O-sulfotransferase 2 |
| chr7_+_130794846 | 1.50 |
ENST00000421797.2
|
MKLN1
|
muskelin 1, intracellular mediator containing kelch motifs |
| chr18_+_29077990 | 1.50 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chr8_-_139926236 | 1.49 |
ENST00000303045.6
ENST00000435777.1 |
COL22A1
|
collagen, type XXII, alpha 1 |
| chr20_+_19870167 | 1.48 |
ENST00000440354.2
|
RIN2
|
Ras and Rab interactor 2 |
| chr2_+_192110199 | 1.48 |
ENST00000304164.4
|
MYO1B
|
myosin IB |
| chr6_-_75915757 | 1.48 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr12_-_123752624 | 1.48 |
ENST00000542174.1
ENST00000535796.1 |
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1 |
| chr1_+_12538594 | 1.48 |
ENST00000543710.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
| chr7_+_116165754 | 1.47 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr4_+_169418255 | 1.46 |
ENST00000505667.1
ENST00000511948.1 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr6_+_30852738 | 1.45 |
ENST00000508312.1
ENST00000512336.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr2_-_216300784 | 1.45 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr10_-_98031310 | 1.44 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
| chr8_+_102504651 | 1.44 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr3_+_49507559 | 1.44 |
ENST00000421560.1
ENST00000308775.2 ENST00000545947.1 ENST00000541308.1 ENST00000539901.1 ENST00000538711.1 ENST00000418588.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr5_-_131630931 | 1.43 |
ENST00000431054.1
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
| chr2_-_214013353 | 1.43 |
ENST00000451136.2
ENST00000421754.2 ENST00000374327.4 ENST00000413091.3 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
Network of associatons between targets according to the STRING database.
First level regulatory network of TCF3_MYOG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 11.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 2.3 | 6.8 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.7 | 6.7 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
| 1.3 | 25.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.2 | 4.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.2 | 3.5 | GO:0048627 | myoblast development(GO:0048627) |
| 1.2 | 3.5 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.1 | 4.6 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 1.1 | 5.4 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 1.1 | 4.3 | GO:1904501 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 1.0 | 3.1 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.0 | 5.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.0 | 3.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.9 | 0.9 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.8 | 4.1 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.8 | 3.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.7 | 2.2 | GO:0008057 | eye pigment granule organization(GO:0008057) |
| 0.7 | 2.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.7 | 6.9 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.7 | 3.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.7 | 4.0 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 0.6 | 3.9 | GO:0018032 | protein amidation(GO:0018032) |
| 0.6 | 2.9 | GO:0021622 | optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.6 | 2.3 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.6 | 5.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.6 | 2.8 | GO:1901545 | cellular response to raffinose(GO:0097403) response to raffinose(GO:1901545) |
| 0.5 | 2.1 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.5 | 2.1 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.5 | 12.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.5 | 3.1 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.5 | 1.4 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 0.5 | 6.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.5 | 3.2 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.5 | 1.4 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.5 | 1.4 | GO:0098976 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 | 0.9 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 | 0.9 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.4 | 0.4 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 0.4 | 2.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
| 0.4 | 15.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 1.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
| 0.4 | 3.5 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.4 | 5.8 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.4 | 1.1 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.4 | 2.6 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 | 3.3 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 | 5.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 | 1.1 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.4 | 1.1 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.4 | 5.3 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.3 | 1.0 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.3 | 2.0 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.3 | 0.3 | GO:0030042 | actin filament depolymerization(GO:0030042) |
| 0.3 | 8.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.3 | 3.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.3 | 1.0 | GO:0060437 | lung growth(GO:0060437) |
| 0.3 | 1.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.3 | 1.6 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
| 0.3 | 0.9 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 | 0.9 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.3 | 0.9 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.3 | 2.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.3 | 1.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 0.3 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.3 | 2.0 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.3 | 1.5 | GO:0021603 | cranial nerve formation(GO:0021603) |
| 0.3 | 1.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.3 | 0.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.3 | 1.7 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 | 1.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.3 | 0.5 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 | 1.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 | 0.8 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.3 | 1.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.3 | 2.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 | 2.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.3 | 0.8 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 0.3 | 2.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.3 | 2.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.3 | 3.0 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.2 | 0.7 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.2 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.2 | 2.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 | 1.4 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 0.9 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.2 | 0.7 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.2 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.2 | 3.0 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 3.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.2 | 0.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 0.2 | 1.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 | 0.9 | GO:0048936 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) cardiac cell fate determination(GO:0060913) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.2 | 1.1 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.2 | 1.1 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.2 | 0.4 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.2 | 2.8 | GO:0009414 | response to water deprivation(GO:0009414) |
| 0.2 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 1.1 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 | 5.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 3.7 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 1.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 1.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 | 2.0 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.2 | 3.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.2 | 6.3 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.2 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 | 2.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.2 | 0.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.2 | 1.0 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.2 | 0.8 | GO:0009956 | radial pattern formation(GO:0009956) |
| 0.2 | 4.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 | 1.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.2 | 2.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.2 | 0.6 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.2 | 1.9 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 0.2 | 1.7 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.2 | 2.2 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.2 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.2 | 1.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 2.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 | 2.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 3.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.2 | 1.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 | 1.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 | 0.8 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
| 0.2 | 0.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.2 | 1.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.2 | 1.2 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.2 | 2.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.2 | 0.6 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
| 0.2 | 5.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 | 1.4 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 9.8 | GO:1901998 | toxin transport(GO:1901998) |
| 0.2 | 1.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.5 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
| 0.2 | 3.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.2 | 0.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.2 | 0.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 | 1.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.2 | 0.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 0.1 | 0.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.3 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.4 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.1 | 0.7 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 | 0.8 | GO:0007296 | vitellogenesis(GO:0007296) |
| 0.1 | 5.1 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 0.1 | 2.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 1.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.1 | 0.4 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 0.5 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 0.5 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.1 | 0.5 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.1 | 1.0 | GO:0006868 | glutamine transport(GO:0006868) L-cystine transport(GO:0015811) |
| 0.1 | 0.3 | GO:0042335 | cuticle development(GO:0042335) |
| 0.1 | 7.2 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 0.1 | 0.5 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 | 3.8 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 2.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.4 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 | 0.5 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 2.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.1 | 6.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.1 | 2.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 1.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 1.2 | GO:0021915 | neural tube development(GO:0021915) |
| 0.1 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 3.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.2 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.1 | 0.7 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 | 1.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.1 | 1.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 | 1.4 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 1.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 | 0.8 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 | 1.1 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 0.1 | 1.3 | GO:0045785 | positive regulation of cell adhesion(GO:0045785) |
| 0.1 | 0.4 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.1 | 0.5 | GO:1902904 | negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.1 | 0.3 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.1 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.1 | 0.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 3.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 1.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.1 | 1.5 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 2.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 1.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 0.1 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
| 0.1 | 1.6 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 1.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.3 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 1.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 1.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.6 | GO:0046596 | regulation of viral entry into host cell(GO:0046596) |
| 0.1 | 1.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 | 3.7 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 0.9 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 1.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 1.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.1 | 5.5 | GO:0031529 | ruffle organization(GO:0031529) |
| 0.1 | 0.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 | 1.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
| 0.1 | 0.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.1 | 0.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.1 | 6.1 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.5 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 1.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 1.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.1 | 0.4 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 1.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.5 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.4 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 2.0 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 4.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 | 8.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.1 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 1.0 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.1 | 0.2 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.1 | 1.5 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 0.1 | 0.9 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.9 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 1.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 1.8 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 | 1.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.2 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 0.1 | 1.5 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.3 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.1 | 0.5 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 | 3.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.3 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.1 | 0.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.1 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 1.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 2.3 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 3.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.8 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 2.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.4 | GO:0098704 | fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 4.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 1.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.1 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.1 | 0.2 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 0.6 | GO:0021515 | cell differentiation in spinal cord(GO:0021515) |
| 0.1 | 1.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 4.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 0.2 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.1 | 0.9 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.1 | 0.4 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 | 0.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.1 | 1.3 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 0.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 0.3 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.2 | GO:0051235 | maintenance of location(GO:0051235) |
| 0.1 | 1.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 0.4 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.0 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 | 0.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.0 | 10.1 | GO:0001764 | neuron migration(GO:0001764) |
| 0.0 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.0 | 2.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 1.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 | 0.2 | GO:0003068 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.0 | 0.6 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.0 | 0.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.0 | 1.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
| 0.0 | 1.2 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.1 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.0 | 0.4 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 | 0.2 | GO:0014041 | regulation of neuron maturation(GO:0014041) negative regulation of neuron maturation(GO:0014043) |
| 0.0 | 1.1 | GO:1904778 | protein localization to cell cortex(GO:0072697) regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 1.2 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.4 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.0 | 0.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.0 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.0 | 0.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 2.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 1.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.0 | 0.6 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.0 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 | 2.7 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 0.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.0 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.0 | 0.4 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.0 | 6.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.2 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 0.0 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.0 | GO:0046958 | nonassociative learning(GO:0046958) habituation(GO:0046959) |
| 0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
| 0.0 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 1.0 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.0 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.1 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 | 0.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.4 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.0 | 0.7 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
| 0.0 | 1.2 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 1.0 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 | 0.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.0 | 0.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 1.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 | 0.5 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.0 | 0.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.0 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 1.9 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.0 | 0.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.0 | 0.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.0 | 0.3 | GO:0051195 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 | 0.1 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.0 | 0.8 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.0 | 1.6 | GO:0002381 | immunoglobulin production involved in immunoglobulin mediated immune response(GO:0002381) |
| 0.0 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.0 | 5.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 | 0.2 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.0 | 0.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.0 | 0.5 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 | 0.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 2.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.1 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.0 | 0.1 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.0 | 0.4 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 | 0.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.0 | 0.7 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.0 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) |
| 0.0 | 0.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 | 0.0 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.0 | 0.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
| 0.0 | 0.1 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 1.7 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.0 | 1.9 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 1.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 | 0.9 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
| 0.0 | 0.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.0 | 0.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 | 1.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 | 0.1 | GO:0009798 | axis specification(GO:0009798) |
| 0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.0 | 1.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.3 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 | 0.5 | GO:0098727 | maintenance of cell number(GO:0098727) |
| 0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 | 0.1 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.0 | 0.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.4 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 | 0.4 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.0 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.0 | 1.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.0 | 0.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.0 | 0.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 | 0.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 1.1 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.0 | 0.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.9 | GO:0006342 | chromatin silencing(GO:0006342) |
| 0.0 | 0.1 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.0 | 0.0 | GO:0018307 | enzyme active site formation(GO:0018307) |
| 0.0 | 0.0 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
| 0.0 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.5 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.1 | GO:0048820 | hair follicle maturation(GO:0048820) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.7 | 2.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.6 | 6.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.5 | 4.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
| 0.5 | 8.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.5 | 1.5 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.4 | 2.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.4 | 0.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.4 | 10.2 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.3 | 2.4 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.3 | 3.8 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 0.9 | GO:0032839 | cell projection cytoplasm(GO:0032838) dendrite cytoplasm(GO:0032839) |
| 0.3 | 8.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.3 | 9.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 3.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.3 | 0.9 | GO:0032173 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.3 | 1.5 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 24.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.3 | 1.1 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.3 | 2.2 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 1.6 | GO:0031673 | H zone(GO:0031673) |
| 0.3 | 3.1 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.2 | 1.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.2 | 4.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.2 | 9.1 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 5.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 3.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 1.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.2 | 1.6 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 3.7 | GO:0045180 | basal cortex(GO:0045180) |
| 0.2 | 5.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 1.2 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.2 | 1.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 5.7 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 2.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 1.0 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.2 | 1.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.2 | 1.2 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.2 | 0.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.1 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 5.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.1 | 13.2 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.1 | 2.9 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 0.6 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.1 | 4.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 1.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.1 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
| 0.1 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 3.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 1.2 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.1 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 1.6 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.4 | GO:0038201 | TOR complex(GO:0038201) |
| 0.1 | 0.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.1 | 4.5 | GO:0000922 | spindle pole(GO:0000922) |
| 0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.2 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 1.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.1 | 3.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 1.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 1.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 1.5 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 1.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 27.7 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.7 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.1 | 1.7 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.1 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.1 | 1.7 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 3.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 1.3 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 1.4 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 2.2 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 1.3 | GO:0005605 | basal lamina(GO:0005605) |
| 0.1 | 10.5 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 2.1 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.0 | 0.8 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 1.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.0 | 1.1 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.0 | 4.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 1.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.0 | 0.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 3.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 3.4 | GO:0005903 | brush border(GO:0005903) |
| 0.0 | 1.1 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.0 | 0.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 3.2 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.0 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.0 | 0.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.0 | 8.2 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 5.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 1.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 3.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.0 | 4.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 2.6 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.0 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.0 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.0 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.0 | 5.8 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.0 | 0.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 1.7 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
| 0.0 | 1.3 | GO:0034399 | nuclear periphery(GO:0034399) |
| 0.0 | 1.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
| 0.0 | 0.2 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.0 | 5.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
| 0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.6 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.0 | 0.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.5 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.0 | 13.0 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.0 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 0.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.0 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.0 | 1.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 0.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.0 | 0.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 1.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.0 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 2.1 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 1.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.0 | 1.0 | GO:0000786 | nucleosome(GO:0000786) |
| 0.0 | 0.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.0 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 1.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.0 | 6.6 | GO:0010008 | endosome membrane(GO:0010008) |
| 0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.0 | 0.6 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.0 | 1.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.3 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.7 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.6 | 24.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.2 | 4.7 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.2 | 3.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.1 | 4.6 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.7 | 3.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.6 | 3.9 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.6 | 2.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.5 | 3.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.5 | 1.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
| 0.5 | 6.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.5 | 1.4 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 0.4 | 5.2 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.4 | 6.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.4 | 3.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.4 | 1.5 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.4 | 1.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 0.4 | 1.1 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.4 | 2.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.4 | 2.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 1.7 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.3 | 1.0 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.3 | 2.8 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 8.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.3 | 2.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.3 | 2.7 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 1.0 | GO:0030545 | receptor regulator activity(GO:0030545) |
| 0.3 | 1.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.2 | 3.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 2.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.2 | 4.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.2 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 5.7 | GO:0016918 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
| 0.2 | 0.7 | GO:0030395 | lactose binding(GO:0030395) |
| 0.2 | 4.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.2 | 1.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 6.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 1.8 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.2 | 5.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.2 | 1.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.2 | 2.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.2 | 3.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.2 | 2.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.2 | 1.4 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 0.5 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.2 | 2.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.2 | 5.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.3 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 4.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 1.0 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.2 | 1.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.2 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 1.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.2 | 1.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.1 | 0.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 3.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 5.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 1.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 2.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.1 | 1.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.1 | 1.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 5.9 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.1 | 1.0 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.1 | 1.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 1.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.1 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.1 | 3.7 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
| 0.1 | 2.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 2.6 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 5.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 1.0 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 1.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 0.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.1 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
| 0.1 | 12.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 7.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.1 | 4.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 2.3 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.1 | 2.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.1 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.1 | 0.4 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
| 0.1 | 0.3 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
| 0.1 | 4.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 3.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 1.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.1 | 1.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 4.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 7.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 1.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.1 | 0.6 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.1 | 0.5 | GO:0004096 | catalase activity(GO:0004096) |
| 0.1 | 3.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 8.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 1.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 0.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.1 | 3.2 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 2.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 0.3 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.8 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 1.0 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
| 0.1 | 2.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 9.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 12.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 1.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 2.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 0.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.1 | 0.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.1 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.1 | 14.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.1 | 13.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 1.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.1 | 0.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.1 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.1 | 1.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.1 | 0.3 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.1 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 2.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.1 | 0.3 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.1 | 1.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 0.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 11.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 2.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 0.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 2.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.1 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 2.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 2.0 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 2.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.4 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 3.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.0 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.0 | 7.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 1.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 1.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.0 | 3.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.0 | 9.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 1.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.0 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 1.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.2 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.0 | 1.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 3.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 1.0 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.0 | 2.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.0 | 0.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.0 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.0 | 2.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 2.1 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 2.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.0 | 1.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 1.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.0 | 0.7 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 16.1 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.0 | 1.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.0 | 0.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.0 | 2.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.0 | 0.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.0 | 0.2 | GO:0015250 | water channel activity(GO:0015250) |
| 0.0 | 1.4 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.0 | 4.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
| 0.0 | 0.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 1.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 1.7 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
| 0.0 | 0.8 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.0 | 1.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 0.7 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.0 | 1.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.5 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.0 | 0.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.0 | 0.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 3.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
| 0.0 | 1.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 3.0 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.0 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.1 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.0 | 0.1 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 0.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 12.4 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.0 | 0.2 | GO:0048185 | activin binding(GO:0048185) |
| 0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
| 0.0 | 0.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.0 | 0.2 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.0 | 0.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.0 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.1 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.0 | 8.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.0 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 4.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 10.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.2 | 8.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 8.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.2 | 8.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 4.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 11.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.2 | 3.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.2 | 9.4 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.2 | 5.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 5.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 8.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 1.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 9.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.1 | 8.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 4.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 8.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.1 | 0.8 | PID FOXO PATHWAY | FoxO family signaling |
| 0.1 | 1.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 2.6 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 3.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 5.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 1.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 0.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 1.9 | PID FGF PATHWAY | FGF signaling pathway |
| 0.0 | 5.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 1.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 4.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 2.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 1.9 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 1.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 1.8 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 1.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.0 | 2.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.6 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.0 | 0.7 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 2.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 5.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 2.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 1.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.0 | 0.6 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.0 | 0.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 1.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.0 | 1.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 1.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.0 | 1.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 2.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 11.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.3 | 8.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 6.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 1.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 7.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.2 | 4.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 2.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 3.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 1.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 3.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.2 | 3.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 5.6 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 4.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 6.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 3.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 5.0 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 18.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 4.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.1 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 5.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 2.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.1 | 1.2 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.1 | 3.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 5.4 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 3.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 2.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 8.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 7.9 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 2.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 1.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 2.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 1.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.1 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 1.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 6.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 1.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.0 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 3.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 1.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 5.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.0 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.0 | 1.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 1.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 1.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.0 | 2.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.0 | 1.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 1.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 2.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.0 | 0.5 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.0 | 1.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.0 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.0 | 1.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 1.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.0 | 3.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 1.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.0 | 2.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 0.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 1.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.0 | 0.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.0 | 0.9 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.0 | 0.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |